The American Cancer Society predicts more than 74,000 Ohioans will be diagnosed with cancer this year alone.
Biomarker testing is a form of so-called Precision medicine that examines a patient's inherited genes to detect variations that could affect how the cancer is treated.
It has played a role in improving cancer outcomes, and now state lawmakers are considering legislation that would require health insurance coverage for such tests.
Colorectal cancer is the second-leading cause of cancer deaths in the United States, and the number of Americans under the age of 55 who are diagnosed with colorectal cancer has nearly doubled over the past decade.
That has medical groups, including the American Cancer Society, lowering the recommended age for a first screening, and that probably involves a colonoscopy.
The Silver Tsunami refers to the unprecedented increase in the number of older Americans. By 2030, every Baby Boomer will be older than 65.
That aging population presents a myriad of health and wellness issues, not the least of which is making sure seniors have a roof over their heads.
Since 1997, CVS Health and Aetna, a CVS Health company, have invested $1.2 billion in affordable senior housing.
Guests:
- Dr. Regan Memmott, Assistant Professor in Medical Oncology, Ohio State Comprehensive Cancer Center
- Dr. Douglas Corley, Gastroenterologist and Research Scientist at Kaiser Permanente Northern California Division of Research
- Mark Stiglitz, Chief Medicare Officer at Aetna, a CVS Health Company
If you have a disability and would like a transcript or other accommodation you can request an alternative format.